4//SEC Filing
Wellisch Alejandro D 4
Accession 0001179110-20-002288
CIK 0000001800other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:34 PM ET
Size
5.4 KB
Accession
0001179110-20-002288
Insider Transaction Report
Form 4
Wellisch Alejandro D
Senior Vice President
Transactions
- Award
Option (right to buy)
2020-02-21+76,198→ 76,198 totalExercise: $87.72From: 2021-02-21Exp: 2030-02-20→ Common shares (76,198 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 25,399 on February 21, 2021, 25,399 on February 21, 2022, and 25,400 on February 21, 2023.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001717526
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:34 PM ET
- Size
- 5.4 KB